key: cord-0823755-v3631w0b
authors: Roncati, Luca; Nasillo, Vincenzo; Lusenti, Beatrice; Riva, Giovanni
title: Signals of T(h)2 immune response from COVID-19 patients requiring intensive care
date: 2020-05-08
journal: Ann Hematol
DOI: 10.1007/s00277-020-04066-7
sha: 9d096918bff028a1d69b458d4cdcfa59df03b14d
doc_id: 823755
cord_uid: v3631w0b

nan

gastrointestinal symptoms present up to 30% of COVID-19 patients and significantly associated with dyspnea [5] ; in fact, hyperperistalsis and gastric fluid acidification are also two notorious default mechanisms of defense to expel parasites governed by T h 2 cytokines [1] .

Conflict of interest The authors declare that they have no conflict of interest.

Ethical approval All procedures followed were in accordance with the ethical standards and with the Helsinki Declaration of 1975, as revised in 2008.

Informed consent Not applicable since the manuscript does not contain any patient data. 

Type 1 / type 2 immunity in infectious diseases

Eosinophils and their interactions with respiratory virus pathogens

The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality

Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells

Clinical characteristics of SARS-CoV-2 infected pneumonia with diarrhea

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations